Astria Therapeutics Inc (NASDAQ: ATXS) Has Succeeded To Excite In 2025, The Stock Is Down -54.81% Year-To-Date
Astria Therapeutics Inc (NASDAQ:ATXS)’s traded shares stood at 0.38 million during the last session, with the company’s beta value hitting 0.56. At the close of